Lemesle G - Search Results

1

IMPELLA^® or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock.

Schurtz G, Rousse N, Saura O, Balmette V, Vincent F, Lamblin N, Porouchani S, Verdier B, Puymirat E, Robin E, Van Belle E, Vincentelli A, Aissaoui N, Delhaye C, Delmas C, Cosenza A, Bonello L, Juthier F, Moussa MD, Lemesle G. Schurtz G, et al. Among authors: lemesle g. J Clin Med. 2021 Feb 14;10(4):759. doi: 10.3390/jcm10040759. J Clin Med. 2021. PMID: 33672792 Free PMC article.

2

High incidence of recurrent in stent thrombosis after successful treatment of a first in stent thrombosis.

Lemesle G, Sudre A, Modine T, Delhaye C, Rosey G, Gourlay T, Bauters C, Lablanche JM. Lemesle G, et al. Catheter Cardiovasc Interv. 2008 Oct 1;72(4):470-8. doi: 10.1002/ccd.21709. Catheter Cardiovasc Interv. 2008. PMID: 18814219

3

Stent thrombosis in 2008: definition, predictors, prognosis and treatment.

Lemesle G, Delhaye C, Bonello L, de Labriolle A, Waksman R, Pichard A. Lemesle G, et al. Arch Cardiovasc Dis. 2008 Nov-Dec;101(11-12):769-77. doi: 10.1016/j.acvd.2008.10.006. Epub 2008 Nov 18. Arch Cardiovasc Dis. 2008. PMID: 19059572 Free article. Review.

4

Impact of high loading and maintenance dose of clopidogrel within the first 15 days after percutaneous coronary intervention on patient outcome.

Lemesle G, Delhaye C, Sudre A, Broucqsault D, Rosey G, Bauters C, Lablanche JM. Lemesle G, et al. Am Heart J. 2009 Feb;157(2):375-82. doi: 10.1016/j.ahj.2008.09.013. Epub 2008 Nov 1. Am Heart J. 2009. PMID: 19185648

5

Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.

Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM. Delhaye C, et al. Among authors: lemesle g. Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005. Cardiovasc Revasc Med. 2009. PMID: 19595394

6

Personalized antiplatelet therapy for coronary artery disease patients: is this the future?

Bonello L, Lemesle G, De Labriolle A, Barragan P, Camoin-Jau L, Paganelli F. Bonello L, et al. Among authors: lemesle g. Expert Rev Cardiovasc Ther. 2009 Dec;7(12):1525-32. doi: 10.1586/erc.09.146. Expert Rev Cardiovasc Ther. 2009. PMID: 19954314 Review.

7

Thrombus aspiration for the treatment of definite stent thrombosis.

Lemesle G, Bouallal R, Sudre A, Delhaye C, Rosey G, Lablanche JM. Lemesle G, et al. Arch Cardiovasc Dis. 2010 Jan;103(1):33-8. doi: 10.1016/j.acvd.2009.10.004. Epub 2010 Jan 15. Arch Cardiovasc Dis. 2010. PMID: 20142118 Free article.

8

Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.

Lemesle G, Maluenda G, Bonello L, Delhaye C, Sudre A, Bauters C, Lablanche JM. Lemesle G, et al. Hosp Pract (1995). 2010 Apr;38(2):50-8. doi: 10.3810/hp.2010.04.294. Hosp Pract (1995). 2010. PMID: 20469613 Review.

9

Should we screen for masked hypertension in patient with vascular disease?

Delsart P, Marboeuf P, Delhaye C, Lemesle G, Mounier-Vehier C. Delsart P, et al. Among authors: lemesle g. Vasc Health Risk Manag. 2010 May 25;6:333-8. doi: 10.2147/vhrm.s9980. Vasc Health Risk Manag. 2010. PMID: 20531952 Free PMC article.

10

Impact of thrombus aspiration use and direct stenting on final myocardial blush score in patients presenting with ST-elevation myocardial infarction.

Lemesle G, Sudre A, Bouallal R, Delhaye C, Rosey G, Bauters C, Lablanche JM. Lemesle G, et al. Cardiovasc Revasc Med. 2010 Jul-Sep;11(3):149-54. doi: 10.1016/j.carrev.2010.03.080. Cardiovasc Revasc Med. 2010. PMID: 20599164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page